FOXP3 and type 1 diabetes mellitus: Other than RORγt, the synergistic effect is also observed in type 1 regulatory T cells (Tr1 cells), which are Foxp3 negative and produce high levels of interleukin 10 (IL-10), and are decreased in adult-onset T1D patients (57–59).